Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 4 × Sezary Syndrome × denileukin diftitox × Clear all

Phase

Phase 4 2 Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2 Dermatologic 2

Conditions

Lymphoma, T-Cell, Cutaneous 3 Sezary Syndrome 2 Mycosis Fungoides 2 Lymphoma, T-Cell 1

Interventions

denileukin diftitox 2 Aprepitant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00050999 2008-03-05

Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients

Eisai Inc.

Phase 4 Completed

DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT00051012 2008-03-05

Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients

Eisai Inc.

Phase 4 Completed

DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡